共 50 条
- [1] PREDICTING ALL-CAUSE AND PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING DEFINITIVE THERAPY FOR LOCALIZED PROSTATE CANCER [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E67 - E67
- [2] DEVELOPMENT OF PROSTATE CANCER SCREENING NOMOGRAMS FOR PREDICTING 15-YEAR RISK OF PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER MORTALITY, WITH OTHER-CAUSE MORTALITY AS COMPETING EVENT [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E606 - E606
- [3] 18-YEAR PROSTATE CANCER-SPECIFIC MORTALITY AFTER PROSTATECTOMY, BRACHYTHERAPY, EXTERNAL BEAM RADIATION THERAPY, HORMONAL THERAPY, OR MONITORING FOR LOCALIZED PROSTATE CANCER [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E737 - E738
- [6] Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (17): : 1460 - 1470
- [7] Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy [J]. JOURNAL OF UROLOGY, 2011, 185 (03): : 869 - 875
- [8] Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1583 - 1584
- [10] Brachytherapy in the curative treatment of localized prostate cancer. [J]. PROGRES EN UROLOGIE, 2000, 10 (01): : 3 - 13